CCND1 and medical procedure: Ogino et al. similarly proposed the existence of molecular differences between CRCs with cyclin D1High and cyclin D1Low; CRCs with cyclin D1Low may have bypassed cyclin D1 activation, resulting in more aggressive behavior than cyclin D1High tumors through the accumulation of multiple genetic and epigenetic events during colorectal carcinogenesis [20].